← FDA ENFORCEMENT
D-0388-2026Class I

ANTHONY TRINH, 123Herbals LLC

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
ANTHONY TRINH, 123Herbals LLC
Product type
Drug
Status
Ongoing
Report date
2026-03-11
Distribution
USA nationwide
Firm state
CA
Product quantity
N/A
Initiated by
Voluntary: Firm initiated
Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Product description

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Code / lot info

All lots within expiry

Other recalls SPEQ maps to Documentation & Change Control
See all Documentation & Change Control recalls →

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →